Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vericiguat and Reverse Remodeling Indices in Heart Failure — Stella

Home/Heart Failure With Reduced Ejection Fraction (HFrEF)/Vericiguat and Reverse Remodeling Indices in Heart Failure

View on ClinicalTrials.gov

Recruiting

Back to Heart Failure With Reduced Ejection Fraction (HFrEF) trials

Vericiguat and Reverse Remodeling Indices in Heart Failure

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Slovenia

University Medical Centre Ljubljana, Ljubljana

Key details

Phase

Post-approval study

Sponsor

University Medical Centre Ljubljana

Collaborators

Slovenian Research Agency

Enrollment target

~60 participants

Started

November 2025

Primary completion

July 2027

Age range

18 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.